My Web Dashboard





SEO News: ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis (RedNova)

SEATTLE, Washington and GENEVA, Switzerland, December 20 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. and Serono (virt-x: SEO and NYSE: SRA) today announced the start of a Phase 2 clinical trial in which atacicept therapy will be evaluated in patients with rheumatoid arthritis (RA).

read more...

Related News